Barinthus Biotherapeutics plc ( BRNS) - Key Metrics
BRNS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.26 | -$0.20 | -$0.20 |
| 2026Q1 | $0 | -$0.14 | -$0.08 | -$0.08 |
| 2025Q4 | $0 | -$0.27 | -$0.10 | -$0.10 |
| 2025Q3 | $0 | -$0.36 | -$0.26 | -$0.26 |
| 2025Q2 | $0 | -$0.52 | -$0.45 | -$0.45 |
BRNS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.63 |
| 2026Q1 | 0% | -1.02 |
| 2025Q4 | 0% | -0.65 |
| 2025Q3 | 0% | -0.87 |
| 2025Q2 | 0% | -0.45 |
BRNS
Price: $0.62
52 week price:
Earnings Per Share: -1.03 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 23.8 million